| chromatin organization | GO:0006325 | 206 | 0.381 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.271 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.166 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.140 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.135 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.123 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.103 | |
| regulation of cell division | GO:0051302 | 76 | 0.102 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.093 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.092 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.091 | |
| cell division | GO:0051301 | 120 | 0.088 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.087 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.087 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.086 | |
| chromatin modification | GO:0016568 | 187 | 0.085 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.084 | |
| organelle fission | GO:0048285 | 170 | 0.082 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.072 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.071 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.070 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.069 | |
| stem cell development | GO:0048864 | 219 | 0.067 | |
| dna repair | GO:0006281 | 107 | 0.065 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.065 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.062 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.062 | |
| gene silencing by rna | GO:0031047 | 19 | 0.060 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.059 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.058 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.058 | |
| organelle assembly | GO:0070925 | 177 | 0.057 | |
| protein processing | GO:0016485 | 163 | 0.057 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.056 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.055 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.052 | |
| rna processing | GO:0006396 | 105 | 0.051 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.051 | |
| centrosome organization | GO:0051297 | 26 | 0.050 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.050 | |
| dna metabolic process | GO:0006259 | 303 | 0.049 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.049 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.048 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.048 | |
| rna interference | GO:0016246 | 2 | 0.046 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.045 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.045 | |
| ossification | GO:0001503 | 216 | 0.044 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.042 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.042 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.042 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.042 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.041 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.040 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.040 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.040 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.039 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.038 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.038 | |
| response to radiation | GO:0009314 | 165 | 0.037 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.037 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.037 | |
| cytoplasmic translational initiation | GO:0002183 | 3 | 0.037 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.036 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.036 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.035 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.034 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.034 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.034 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.034 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.033 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.032 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.032 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.032 | |
| stem cell differentiation | GO:0048863 | 268 | 0.031 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.031 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.031 | |
| protein localization to organelle | GO:0033365 | 185 | 0.031 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.030 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.030 | |
| compound eye development | GO:0048749 | 1 | 0.030 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.030 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.030 | |
| forebrain development | GO:0030900 | 302 | 0.030 | |
| protein maturation | GO:0051604 | 176 | 0.029 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.029 | |
| blastocyst development | GO:0001824 | 80 | 0.029 | |
| oocyte axis specification | GO:0007309 | 2 | 0.029 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.029 | |
| histone modification | GO:0016570 | 159 | 0.029 | |
| atp catabolic process | GO:0006200 | 55 | 0.028 | |
| maintenance of location | GO:0051235 | 89 | 0.028 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.028 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.028 | |
| heterochromatin organization | GO:0070828 | 4 | 0.028 | |
| microtubule based process | GO:0007017 | 236 | 0.028 | |
| stem cell maintenance | GO:0019827 | 130 | 0.027 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.027 | |
| kinetochore organization | GO:0051383 | 2 | 0.027 | |
| regulation of protein localization | GO:0032880 | 231 | 0.027 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.027 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.026 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.026 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.026 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.025 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.025 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.024 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.024 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.024 | |
| rna splicing | GO:0008380 | 54 | 0.023 | |
| dendrite development | GO:0016358 | 115 | 0.023 | |
| cell growth | GO:0016049 | 130 | 0.023 | |
| centrosome cycle | GO:0007098 | 23 | 0.022 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.022 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.022 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.022 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.022 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.022 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.021 | |
| cellular response to radiation | GO:0071478 | 28 | 0.021 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.021 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.021 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.021 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.021 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.021 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.021 | |
| muscle tissue development | GO:0060537 | 308 | 0.021 | |
| mrna transport | GO:0051028 | 13 | 0.020 | |
| atp metabolic process | GO:0046034 | 75 | 0.020 | |
| cellular response to lipid | GO:0071396 | 145 | 0.020 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.020 | |
| regulation of binding | GO:0051098 | 111 | 0.019 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.019 | |
| regulation of histone modification | GO:0031056 | 56 | 0.019 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.019 | |
| pigmentation | GO:0043473 | 71 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.019 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.019 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.018 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.018 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.018 | |
| heterochromatin assembly | GO:0031507 | 2 | 0.018 | |
| cellular response to light stimulus | GO:0071482 | 19 | 0.018 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.017 | |
| lateral inhibition | GO:0046331 | 1 | 0.017 | |
| organelle localization | GO:0051640 | 179 | 0.017 | |
| intracellular protein transport | GO:0006886 | 204 | 0.017 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.017 | |
| centrosome duplication | GO:0051298 | 16 | 0.017 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.017 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.017 | |
| ear development | GO:0043583 | 200 | 0.017 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.017 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.016 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.016 | |
| double strand break repair | GO:0006302 | 48 | 0.016 | |
| chromosome segregation | GO:0007059 | 48 | 0.016 | |
| protein targeting | GO:0006605 | 143 | 0.016 | |
| gene silencing | GO:0016458 | 38 | 0.016 | |
| liver development | GO:0001889 | 66 | 0.016 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.016 | |
| cation transport | GO:0006812 | 399 | 0.016 | |
| translation | GO:0006412 | 93 | 0.016 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.016 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.016 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.016 | |
| gastrulation | GO:0007369 | 116 | 0.016 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.016 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.015 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.015 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.015 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.015 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.015 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.015 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.015 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.015 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.015 | |
| amine metabolic process | GO:0009308 | 45 | 0.015 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.014 | |
| neuron death | GO:0070997 | 154 | 0.014 | |
| germ cell development | GO:0007281 | 185 | 0.014 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.014 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.014 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.014 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.014 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.014 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.014 | |
| regulation of protein stability | GO:0031647 | 52 | 0.014 | |
| gland development | GO:0048732 | 330 | 0.014 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.014 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.013 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.013 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.013 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.013 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.013 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.013 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.013 | |
| regulation of cell migration | GO:0030334 | 219 | 0.013 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.013 | |
| nuclear import | GO:0051170 | 95 | 0.013 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.013 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.013 | |
| action potential | GO:0001508 | 78 | 0.013 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.013 | |
| telomere maintenance | GO:0000723 | 19 | 0.013 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.012 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.012 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.012 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.012 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.012 | |
| immune effector process | GO:0002252 | 321 | 0.012 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.012 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.012 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.012 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.012 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.012 | |
| mapk cascade | GO:0000165 | 281 | 0.012 | |
| cell fate commitment | GO:0045165 | 210 | 0.012 | |
| innate immune response | GO:0045087 | 157 | 0.012 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.012 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.012 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.011 | |
| chromatin silencing | GO:0006342 | 15 | 0.011 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.011 | |
| regulation of neuron death | GO:1901214 | 134 | 0.011 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.011 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.011 | |
| nucleus organization | GO:0006997 | 45 | 0.011 | |
| protein catabolic process | GO:0030163 | 221 | 0.011 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.011 | |
| microtubule nucleation | GO:0007020 | 2 | 0.011 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.011 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.011 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.011 | |
| lipid localization | GO:0010876 | 126 | 0.011 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.011 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.011 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.011 | |
| angiogenesis | GO:0001525 | 201 | 0.011 | |
| heart morphogenesis | GO:0003007 | 178 | 0.011 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.011 | |
| locomotory behavior | GO:0007626 | 195 | 0.010 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.010 | |
| membrane organization | GO:0061024 | 245 | 0.010 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.010 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.010 | |
| cell adhesion | GO:0007155 | 329 | 0.010 | |
| ncrna processing | GO:0034470 | 26 | 0.010 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.010 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.010 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.010 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.010 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.010 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.010 | |
| adult behavior | GO:0030534 | 135 | 0.010 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.010 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.010 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.010 | |
| jak stat cascade | GO:0007259 | 42 | 0.010 | |
